Bristol Myers Squibb is taking a strategic leap, offloading five immunology assets, including three in clinical stages, to a ...

Bain Capital and Bristol Myers Squibb have formed a new biopharmaceutical company focused on developing new therapies for autoimmune diseases. The newly formed company launches with a $300 million ...

Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...

Bristol Myers Squibb and Bain Capital launch a new biopharma firm focused on autoimmune disease treatments, starting with 5 ...

The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which ...

Shares of healthcare company Surgery Partners (NASDAQ:SGRY) jumped 4.3% in the morning session after Bank of America ...

We recently compiled a list of 11 Best Undervalued Stocks to Invest in Now. Lincoln National Corporation stands third on our ...

King and Wood Mallesons ( KWM) and A&O Shearman have acted for Australian wealth manager Insignia Financial and a group of ...

Large private investment firm, Bain Capital, plans to sell its majority stake in an insurance broker and agency network based ...

Bain Capital is on the cusp of signing a deal to buy UK broker Jensten from private equity (PE) firm Livingbridge, Insurance ...

Charta Health built an artificial-intelligence-powered platform to optimize medical billing and coding. The three-year-old ...

Private-duty nursing has become an attractive target for private equity (PE) investors. However, a new report states that care quality and market ...